Pricing Log in Create free account

Fulgent Genetics, Inc. (FLGT) vs GeneDx Holdings Corp. (WGS)

Fulgent Genetics, Inc. and GeneDx Holdings Corp. are both Diagnostics & Research companies. GeneDx Holdings Corp. is the larger, with a market value of $1.9B against $513.4M — 3.7× the size. GeneDx Holdings Corp. grew revenue faster over the last twelve months: 25.4% against 4.67%. GeneDx Holdings Corp. has the higher net margin (−23.4% vs −27.5%) and the lower return on invested capital (−27.7% vs −8.22%). Across the 18 metrics below, Fulgent Genetics, Inc. leads on 10 and GeneDx Holdings Corp. on 8.

Valuation

Metric FLGT WGS Diagnostics & Research median
P/E n/m n/m 34.52
P/S 1.56 4.24 4.24
P/B 0.52 7.89 3.42
Price to free cash flow n/m n/m 33.51
EV/EBITDA n/m n/m 23.44
EV/Sales 0.85 4.16 5.18
Earnings yield (16.56%) (5.61%) (1.50%)
Free cash flow yield (1.09%) (3.93%) 0.00%

Profitability

Metric FLGT WGS Diagnostics & Research median
Gross margin 33.82% 69.37% 48.32%
Operating margin (39.20%) (20.34%) (5.68%)
Net margin (27.53%) (23.40%) (4.10%)
Free cash flow margin 4.37% (16.68%) 0.00%
Return on equity (8.64%) (40.80%) 0.00%
Return on assets (7.93%) (22.50%) (6.05%)
Return on invested capital (8.22%) (27.70%) 0.00%

Growth

Metric FLGT WGS Diagnostics & Research median
Revenue growth (TTM) 4.67% 25.42% 8.99%
EPS growth (last fiscal year) (39.72%) 62.37% 20.36%
Revenue growth, 5-year CAGR (5.21%) 18.98% 7.30%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric FLGT WGS Diagnostics & Research median
Debt to equity 0.00 0.40 0.01
Current ratio 5.34 3.30 2.27
Net debt to EBITDA 4.66 (10.13) 0.68

Dividend

Metric FLGT WGS Diagnostics & Research median
Dividend yield — — 0.67%
Payout ratio — — 0.20

Size

Metric FLGT WGS Diagnostics & Research median
Market cap 513.43m 1.92b 2.22b

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack